{"url_path":"/sec/oncy/8-k/2026-06-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1129928/0001129928-26-000039-index.html","accession_number":"0001129928-26-000039","cik":"0001129928","ticker":"ONCY","issuer_name":"ONCOLYTICS BIOTECH INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1129928/0001129928-26-000039-index.html","primary_entity_key":"0001129928","primary_entity_name":"ONCOLYTICS BIOTECH INC"},"word_count":73,"has_tables":true,"body_markdown":"Item 8.01. Other Events.\n\nOn June 2, 2026, the Company issued a press release announcing the appointments of Stephen Glover to the Board and John McAdory as Chief Operating Officer. The information set forth in this Item 8.01 and in Exhibit 99.1 is furnished and shall not be deemed \"filed\" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section."}